WINTON GROUP Ltd - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 140 filers reported holding HERON THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.52 and the average weighting 0.8%.

Quarter-by-quarter ownership
WINTON GROUP Ltd ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$288,000
-72.1%
13,621
-80.4%
0.02%
-38.2%
Q3 2020$1,032,000
-42.1%
69,611
-42.6%
0.03%
-26.1%
Q2 2020$1,783,000
+96.1%
121,190
+56.5%
0.05%
+91.7%
Q1 2020$909,000
-30.8%
77,444
+38.6%
0.02%
+33.3%
Q4 2019$1,313,000
+144.1%
55,867
+92.0%
0.02%
+200.0%
Q3 2019$538,000
+152.6%
29,098
+233.5%
0.01%
+50.0%
Q1 2019$213,0008,7240.00%
Other shareholders
HERON THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
TANG KEVIN C 760$1,900100.00%
Velan Capital Investment Management LP 2,500,000$6,250,0005.52%
GREAT POINT PARTNERS LLC 6,360,161$15,900,4033.12%
Cheyne Capital Management (UK) LLP 318,008$795,0201.39%
TANG CAPITAL MANAGEMENT LLC 3,755,934$9,389,8351.36%
Rubric Capital Management LP 11,750,000$29,375,0001.28%
Orchard Capital Management, LLC 1,391,080$3,477,7001.17%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 267,028$667,5700.81%
CM Management, LLC 250,000$6250.75%
Tejara Capital Ltd 493,619$1,234,0480.71%
View complete list of HERON THERAPEUTICS INC shareholders